ABOUT
Sheila Botts - Pharm.D., BCPP
Dr. Botts is a board certified psychiatric pharmacy specialist and provides medication management services for veterans receiving care at the Lexington VA mental health clinic as well as inpatient service. She directs the PGY2 residency training program in psychiatric pharmacy and also precepts PGY1 residents in area of psychiatry. She coordinates and teaches the psychiatry module in Integrated Therapeutics for doctor of pharmacy students and coordinates an elective in Chemical Dependency.
Dr. Botts is a founding member of the College of Psychiatric and Neurologic Pharmacists (CPNP) and is currently President-elect of the organization (2006-2007). CPNP, founded in 1996, is committed to improving the lives of patients with mental illness through advanced pharmacy practice, education and research. Additionally, Dr. Botts is also active in both the American College of Clinical Pharmacy and the American Society of Health-systems Pharmacists. She has served as Chair of the Psychiatry and Neurology specialty group for both organizations and has participated on multiple committees.
Selected Publications/Presentations
- From 9/11 to the War in Iraq: An Update on Post-Traumatic Stress Disorder. Presented at: American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting; 2007 December; Las Vegas, NV.
- Botts S, Bettinger T, Greenlee B. Generalized Anxiety Disorder, Panic Disorder and Social Anxiety Disorder. Chapter in Wells et al eds. Pharmacotherapy Principles and Practice. McGraw Hill Publishing. In press
- Botts SR, Eatmon CV, Ryan MA. Evaluation of acetylcholinesterase inhibitor formulary therapeutic substitution in a Veterans Affairs population.(Abstract) Pharmacotherapy 2006; 26(3);1430
- Botts SR, Ryan MA, Coffey GL. Depression. Chapter in Tisdale J, Miller D eds. Drug Induced Diseases: Prevention, Detection, and Management. ASHP Inc. 2005 205-216
- Botts S. Moving beyond balance for a better antidepressant. Am J Health Syst Pharm. 2005 Dec 1;62(23):2479
- Coffey GL, Botts SR, de Leon J High vulnerability to acute dystonic reactions: A case of antipsychotic exposure and uncontrolled seizure activity. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun;29(5):770-4.
- Botts SR, Littrell RA, de Leon J. High Olanzapine Dosing in a State Hospital. Journal of Clinical Psychiatry, 2004 Aug;65(8):1138-43
- Coffey GL, Botts SR, de Leon J. Dosing differences between valproic acid concentrate and divalproex sodium: A case report. Journal of Clinical Psychiatry. 2004 May;65(5):724-5
- Botts SR, Hines H, Littrell RA. Antipsychotic polypharmacy in the ambulatory care setting: 1993-2000. Psychiatric Services. 2003;54(8):1086
- Botts SR, Alfaro CL. Antidepressant Drug Interactions. Journal of Pharmacy Practice. 2001;14(6):467-477
- Bonanno DG, Davydov L, Botts SR. Olanzapine-induced Diabetes Mellitus. The Annals of Pharmacotherapy. 2001;35:563-5
- Contributor. In: Lefor A, Gomella LG, ed. Surgery On Call. 4th ed. New York, NY: McGraw Hill; 2005.
- Davydov L, Botts SR. Clozapine Induced Hypersalivation. The Annals of Pharmacotherapy. 2000;34(5):662-5
- Botts SR, Raskind J. The Role of Gabapentin and Lamotrigine in Bipolar Disorder. American Journal of Health-Systems Pharmacist. 1999; 56:1939-44
Selected Grants
- PI:Sheila Botts, Mentor: Joseph Conigliaro, Co-I: Doug Steinke, Sponsor: ASHP Foundation, Program: Federal Services Junior Investigator Research Grant, Title: Evaluation of Medication Non-Adherence and Associated Factors in Posttraumatic Stress Disorder, Funding: $25,000
- PI: Sheila Botts, Sponsor: ACCP, Program: Focused Investigator Program, Title: Cultural Determinants of Quality Care of Depression in Impoverished, Rural Health Populations